B-type natriuretic peptide: A simple new test to identify coronary artery disease?

QJM: An International Journal of Medicine

Volumn 98, Issue 10, 2005, Pages 765-769

  Struthers, A D ^a   Davies, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANGINA PECTORIS; ANGIOGRAPHY; BLOOD EXAMINATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXERCISE TEST; HEART DEATH; HEART FAILURE; HEART PROTECTION; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

EID: 27644545057     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hci111     Document Type: Review

References (28)

1. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G. Clinical applications of β-type natriuretic peptide (BNP) testing. Eur Heart J 2003; 24:1710-18.
2. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-63.
3. Gaede P, Hildebrandt P, Hess G, Parving HH, Pedersen O. Plasma N-terminal pro BNP as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia 2005; 48:156-63.
4. Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH. Plasma N-terminal pro BNP as an independent predictor of mortality in diabetic nephropathy. Diabetologia 2005; 48:149-55.
5. Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS. Prognostic role of BNP levels in Type 2 diabetes mellitus. J Am Coll Cardiol 2004; 44:1047-52.
6. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E. The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes. N Engl J Med 2001; 345:1014-21.
7. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K. N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes. Circulation 2002; 106:2913-18.
8. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002; 40:437-45.
9. de Lemos JA, Morrow DA. Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application? Circulation 2002; 106:2868-70.
10. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Münzel JT, Cambien F, Tiret L, Blankenberg S for the AtheroGene Investigators. Analysis of N-terminal pro BNP and CRP for risk stratification in stable and unstable coronary artery disease: Results from the AtheroGene study. Eur Heart J 2005; 26:241-9.
11. Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R. N-terminal pro BNP and long term mortality in stable coronary heart disease. N Engl J Med 2005; 352:666-75.
12. Davidson N, Pringle S, Pringle T, McNeill G, Struthers A. Right coronary artery stenosis is associated with impaired cardiac endocrine function during exercise. Eur Heart J 1997; 18:1749-54.
13. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiac expression associated with myocardial ischaemia. FASEB J 2003; 17:1105-7.
14. Hopkins W, Chen Z, Fukaguwa N, Hall C, Knot H, LeWinter M. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease. Circulation 2004; 109:2872-7.
15. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma BNP after percutaneous transluminal coronary angiography. Clin Cardiol 2000; 23:776-80.
16. Kalra PR, Gomma A, Daly C, Clague MR, Squire I, Ng LL, Fox KF. Reduction in plasma concentrates of N terminal pro BNP following percutaneous coronary intervention. Heart 2004; 90:1334-5.
17. Bibbins-Domingo K, Ansori M, Schiller NB, Massie B, Whealley MA. BNP and ischemia in patients with stable coronary disease. Circulation 2003; 108:2987-92.
18. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, DiBattiste PM, Morrow DA, de Lemos JA, Braunwald E, Gibson CM. Association of elevated BNP with angiographic finding among patients with unstable angina and ST segment elevation MI. J Am Coll Cardiol 2004; 44:564-8.
19. Asada J, Tsuji H, Iwasaka T, Thomas JD, Lauer MS. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine induced myocardial ischaemia. Am J Cardiol 2004; 93:702-4.
20. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Müller KD, Berkovitsch A, Mitrovic V, Hamm C. N terminal BNP predicts extent of coronary artery disease and ischaemia in patients with stable angina pectoris. Am Heart J 2004; 148:612-20.
21. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow BP. Long term survival after first ever stroke: The Oxfordshire Community Stroke Project. Stroke 1993; 24:796-800.
22. Davies JI, Rana BS, Band MM, Pringle ID, Morris AD, Struthers AD. BNP detects silent ischaemia on exercise testing in type II diabetic patients. Heart 2005; 91 (Suppl. 1):A45.
23. Davidson NC, Naas A, Hanson JK, Kennedy N, Coutie WJ, Struthers AD. Comparison of ANP, BNP and N-terminal pro ANP as indicators of LV systolic dysfunction. Am J Cardiol 1996; 77:828-831.
24. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357:995-1001.
25. Hall L, Jung R, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. Br Med J 2003; 326:251-2.
26. WHO/ISH report. WHO/ISH guidelines for the managernent of hypertension. J Hypertension 1999; 17:151-83.
27. Takase H, Toriyama T, Sugiura T, Ueda R, Dohi Y. Brain natriuretic peptide in the prediction of recurrence of angina pectoris. Eur J Clin Invest 2004; 34:79-84.
28. Troughton RW, Frampton CM, Yandle TG, Espine EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-30.